Abstract | INTRODUCTION:
Ovarian cancer is generally diagnosed at advanced stages of the disease; therefore, poor prognoses are typical. The development of tumor markers is thus of utmost importance. Prostasin is a protease that in normal tissues is highly expressed only in the prostate gland and seminal fluid. A previous study showed that prostasin is highly overexpressed in ovarian cancer cell lines. This study sought to evaluate the expression of prostasin in ovarian cancer. METHODS: RESULTS: Using conventional PCR, prostasin was detected in all but one sample. Using quantitative PCR, prostasin was over-expressed in all but one of the samples as compared to the control (prostate). CONCLUSIONS:
|
Authors | Fernanda Pires Costa, Eraldo Luis Batista Jr, Alice Zelmanowicz, Christer Svedman, Gabriela Devenz, Silvana Alves, Andrea Simões Martins da Silva, Bernardo Garicochea |
Journal | Clinics (Sao Paulo, Brazil)
(Clinics (Sao Paulo))
Vol. 64
Issue 7
Pg. 641-4
( 2009)
ISSN: 1980-5322 [Electronic] United States |
PMID | 19606239
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers, Tumor
- Neoplasm Proteins
- Serine Endopeptidases
- prostasin
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Biomarkers, Tumor
(blood)
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Mass Screening
(methods)
- Middle Aged
- Neoplasm Proteins
(blood)
- Ovarian Neoplasms
(diagnosis, enzymology)
- Pilot Projects
- Reverse Transcriptase Polymerase Chain Reaction
- Serine Endopeptidases
(blood)
|